Tunis has begun manufacturing anti-malaria drug hydroxychloroquine locally, reported France 24.
In a special report, the light was shed on laboratory working non-stop to produce drugs to combat the virus. The lab has shifted its focus on manufacturing hydroxychloroquine. Thinking about producing the drug begun before the pandemic, said Deputy director-general of laboratories Kais Haji. Stocks of materials were build to speed up the manufacturing. Moreover, a fist batch was already made it will be provided once the ministry gives the green light with an order placed in raw material to avoid a shortage, adds the report.
Tunisia has also seen its debate on the use of the drug however, many physicians are in favour of using it under certain conditions.
Agnes Hamzaoui a pneumology doctor at Abderrahmen Mami hospital affirmed that positive results have been recorded, adding that patients can be monitored for any side effects.
What's happening in Tunisia?
Subscribe to our Youtube channel for updates.
